As the government allows emergency use clearance for foreign vaccines to give the pace of inoculation a big push, Forbes India explores what difference it will make to the existing supply capacities
A brick kiln worker receives a dose of COVISHIELD, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, at Kavitha village on the outskirts of Ahmedabad, India, April 8, 2021.
Image: Amit Dave / REUTERS